You are here  Home  Program  Session Descriptions  Scientific Forums  

Medicinal Chemistry

Date: September 24 & 25, Wednesday & Thursday (afternoon)       
Room: Room 3
Organizers:John Harris, Anne Hersey

Medicinal Chemistry - Chemical Biology and Applications, Druggability and Drug Properties

08:30 - 09:00
The use of virtual screening, DSF and microscale thermophoresis for the rapid identification of fragments active against MEK1
A. Rak (Structure-Design-Informatics / LGCR / Sanofi R&D, Vitry sur Seine Cedex, France)

09:00 - 09:45
Sulfa drugs and tetrahydrobiopterin biosynthesis
K. Johnsson (École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland)

09:45 - 10:15
What can we learn from the evolution of protein-ligand interactions to aid the design of new therapeutics?
A.P. Higueruelo (University of Cambridge, Cambridge, United Kingdom)

10:15 - 10:45
Coffe Break

10:45 - 11:30
Pursuing compound quality
P.D. Leeson (GlaxoSmithKline, Stevenage, United Kingdom)

11:30 - 12:00
Chemical space for drug discovery
J.L. Reymond (University of Berne, Berne, Switzerland)


Medicinal Chemistry - Anit-infectives

14:30 - 15:15
Overcoming Resistance with bea-Lactams
E. Desarbre (Basilea, Basel, Switzerland)

15:15 - 15:45
Conventional and unconventional approaches to tuberculosis drug discovery
S. Cole (École Polythechnique Fédérale de Lausanne, Lausanne, Switzerland)

15:45 - 16:15
Next-generation antimalarials aimed at the malaria eradication agenda: Medicines for Malaria Venture's R&D portfolio
B. Campo (Medicines for Malaria Venture, Geneva, Switzerland)

16:15 - 16:45
Coffee Break


Link to the Opens internal link in current windowInteractive Planner
Please subscribe to our Newsletter so stay informed about the latest updates.

Sponsoring Item 3:

Sponsoring Item 1: